Boydsense
French tech company | Builders Republic
About
Medtech developer of a non-invasive glucose monitor for people with diabetes — a handheld breath analyzer, named Lassie, that reads volatile organic compounds in exhaled air to estimate blood glucose without finger pricks or implants, transmitting readings to a phone.
Key facts
- Status
- Active
- Sectors
- Healthcare & Life Sciences
- Latest stage
- Series B
- Founded
- 2015
- City
- TOULOUSE
- Region
- Occitanie
- Tracked rounds
- 1
- Amount raised
- 5.5 M€ raised since 2020
Funding rounds
- Series B — 2024
Investors
- Ambrosia Investments
- Bioserenity
- EIC
- Jolt Capital
- Swiss Diabetes Venture Fund